rituximab

navigate by keyword : peripheral blood neutropenia rituximab granulocytes complication lymphomas anti cd20 monoclonal antibody wright smear mabthera hematology oncology cytology microscope clinical medical laboratory fever

Neutropenia due to Rituximab. Bone marrow. Royalty Free Stock Photo
Neutropenia due to Rituximab. Bone marrow. Royalty Free Stock Photo
Neutropenia due to Rituximab. Bone marrow. Royalty Free Stock Photo
Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
Neutropenia due to Rituximab. Peripheral blood.
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Peripheral blood smear with neutropenia due to Rituximab. Note the absence of granulocytes in the smear. Neutropenia can be a complication in the treatment of lymphomas with the anti-CD20 monoclonal antibody. Wright, peripheral blood x1000.


Stockphotos.ro (c) 2026. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.